MARS - Monitored Atherosclerosis Regression Study
NCT00116870
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
270
Enrollment
INDUSTRY
Sponsor class
Conditions
Atherosclerosis
Coronary Artery Disease
Interventions
DRUG:
lovastatin
Sponsor
Merck Sharp & Dohme LLC